Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets

Breast cancer, comprising of several sub-phenotypes, is a leading cause of female cancer-related mortality in the UK and accounts for 15% of all cancer cases. Chemoresistant sub phenotypes of breast cancer remain a particular challenge. However, the rapidly-growing availability of clinical datasets,...

Descripción completa

Detalles Bibliográficos
Autores principales: Alnoumas, Layla, van den Driest, Lisa, Apczynski, Zoe, Lannigan, Alison, Johnson, Caroline H., Rattray, Nicholas J. W., Rattray, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364282/
https://www.ncbi.nlm.nih.gov/pubmed/35948941
http://dx.doi.org/10.1186/s12885-022-09969-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364282/
https://www.ncbi.nlm.nih.gov/pubmed/35948941
http://dx.doi.org/10.1186/s12885-022-09969-4

Ejemplares similares